Zensun (Shanghai) Sci & Tech Co., Ltd. – Product Pipeline Review – 2013 5/27/2013 \| published by: Global Markets Direct ... on the Zensun (Shanghai) Sci & Tech Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is ... \| read more...	$1,500.00
ManRos Therapeutics – Product Pipeline Review – 2013 5/27/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ManRos Therapeutics’s corporate ... \| read more...	$1,500.00
Intermittent Claudication – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Intermittent Claudication, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Intermittent Claudication. Intermittent Claudication - Pipeline Review, Half Year ... \| read more...	$2,000.00
Malignant Glioma – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Malignant Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Malignant Glioma. Malignant Glioma - Pipeline Review, Half Year ... \| read more...	$2,000.00
Male Infertility – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Male Infertility, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Male Infertility. Male Infertility - Pipeline Review, Half Year ... \| read more...	$2,000.00
Fabry Disease – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Fabry Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fabry Disease. Fabry Disease - Pipeline Review, Half Year ... \| read more...	$2,000.00
Respiratory Distress Syndrome – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... therapeutic development for Respiratory Distress Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Respiratory Distress Syndrome. Respiratory Distress Syndrome ... \| read more...	$2,000.00
Sarcoidosis – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sarcoidosis. Sarcoidosis - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... therapeutic pipeline. This report provides information on the therapeutic development for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ... \| read more...	$2,000.00
Brain Ischemia – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Brain Ischemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Brain Ischemia. Brain Ischemia - Pipeline Review, Half Year ... \| read more...	$2,000.00
Enterovirus Infections – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Enterovirus Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Enterovirus Infections. Enterovirus Infections - Pipeline Review, Half Year ... \| read more...	$2,000.00
Aneurysmal Subarachnoid Hemorrhage (SAH) – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... on the therapeutic development for Aneurysmal Subarachnoid Hemorrhage (SAH), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Aneurysmal Subarachnoid Hemorrhage ... \| read more...	$2,000.00
Myasthenia Gravis – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Myasthenia Gravis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Myasthenia Gravis. Myasthenia Gravis - Pipeline Review, Half Year ... \| read more...	$2,000.00
Skin And Skin Structure Infections (SSSI) Caused By Bacteria – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Skin And Skin Structure Infections (SSSI) Caused By Bacteria, complete with latest updates, and special features on late-stage and discontinued ... \| read more...	$2,000.00
Birch Pollen Allergy – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... therapeutic development for Birch Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Birch Pollen Allergy. Birch Pollen Allergy ... \| read more...	$2,000.00
IntelGenx Corp. – Product Pipeline Review – 2013 5/27/2013 \| published by: Global Markets Direct ... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, IntelGenx Corp.’s corporate ... \| read more...	$1,500.00
Teva Pharmaceutical Industries Limited – Product Pipeline Review – 2013 5/27/2013 \| published by: Global Markets Direct ... research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets ... \| read more...	$1,500.00
Hemorrhage – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hemorrhage. Hemorrhage - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Gynecological Cancer – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Gynecological Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gynecological Cancer. Gynecological Cancer - Pipeline Review, Half Year ... \| read more...	$2,500.00
MediPoint: Breast Cancer Imaging - US Analysis and Market Forecasts 5/27/2013 \| published by: GlobalData ... in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of western lifestyle risk factors. Early diagnosis of breast cancer is the foundation for increasing survival rates ... \| read more...	$4,450.00
Diabetic Complications – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Diabetic Complications, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Complications. Diabetic Complications - Pipeline Review, Half Year ... \| read more...	$2,000.00
Mixed Dyslipidemia – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Mixed Dyslipidemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Mixed Dyslipidemia. Mixed Dyslipidemia - Pipeline Review, Half Year ... \| read more...	$2,000.00
Neurofibromatoses – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neurofibromatoses. Neurofibromatoses - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Cellulite – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cellulite. Cellulite - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Dental Pain – Pipeline Review, H1 2013 5/27/2013 \| published by: Global Markets Direct ... for Dental Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Pain. Dental Pain - Pipeline Review, Half Year ... \| read more...	$2,000.00

< prev 4 5 6 7 8 9 10 11 12 13 next >